News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
884,610 Results
Type
Article (88842)
Company Profile (816)
Press Release (794930)
Multimedia
Podcasts (240)
Webinars (35)
Section
Business (233620)
Career Advice (4163)
Deals (40003)
Drug Delivery (179)
Drug Development (91739)
Employer Resources (207)
FDA (18566)
Job Trends (17490)
News (398795)
Policy (40018)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3055)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (42)
Allergies (208)
Alliances (56990)
ALS (239)
Alzheimer's disease (1983)
Antibody-drug conjugate (ADC) (565)
Approvals (18930)
Artificial intelligence (893)
ASCO (345)
Autoimmune disease (366)
Automation (66)
Bankruptcy (409)
Best Places to Work (12635)
BIO (67)
BIOSECURE Act (23)
Biosimilars (250)
Biotechnology (480)
Bladder cancer (213)
Brain cancer (85)
Breast cancer (842)
Cancer (6664)
Cardiovascular disease (562)
Career advice (3599)
Career pathing (52)
CAR-T (388)
CDC (77)
Celiac Disease (3)
Cell therapy (1083)
Cervical cancer (56)
Clinical research (79171)
Collaboration (2404)
Commercialization (1)
Company closure (8)
Compensation (1541)
Complete response letters (107)
COVID-19 (3043)
CRISPR (126)
C-suite (1311)
Cystic fibrosis (168)
Data (8820)
Decentralized trials (3)
Denatured (92)
Depression (199)
Dermatology (99)
Diabetes (714)
Diagnostics (7615)
Digital health (71)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (443)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (320)
Earnings (102507)
Editorial (80)
Employer branding (25)
Employer resources (174)
Events (138828)
Executive appointments (1204)
FDA (22708)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1979)
Gene editing (274)
Generative AI (91)
Gene therapy (859)
GLP-1 (1290)
Government (5565)
Grass and pollen (8)
Guidances (422)
Healthcare (21268)
Hematology (198)
HIV (98)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (360)
Immuno-oncology (116)
Indications (214)
Infectious disease (3450)
Inflammatory bowel disease (245)
Inflation Reduction Act (17)
Influenza (153)
Intellectual property (327)
Interviews (822)
IPO (18007)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (23)
Labor market (125)
Layoffs (690)
Leadership (53)
Legal (10171)
Liver cancer (111)
Longevity (38)
Lung cancer (880)
Lymphoma (482)
Machine learning (69)
Management (66)
Manufacturing (1258)
Marketing (2)
MASH (229)
Medical affairs (1)
Medical device (15289)
Medtech (15461)
Mergers & acquisitions (23315)
Metabolic disorders (1846)
mRNA (273)
Multiple sclerosis (208)
NASH (24)
Neurodegenerative disease (519)
Neuropsychiatric disorders (130)
Neuroscience (3763)
Neurotech (2)
NextGen: Class of 2026 (7716)
Non-profit (5147)
Now hiring (82)
Obesity (878)
Opinion (375)
Ovarian cancer (247)
Pain (287)
Pancreatic cancer (366)
Parkinson's disease (422)
Partnered (41)
Patents (666)
Patient recruitment (778)
Peanut (71)
People (68072)
Pharmaceutical (136)
Pharmacy benefit managers (38)
Phase 1 (24466)
Phase 2 (34398)
Phase 3 (25861)
Pipeline (9974)
Policy (402)
Postmarket research (3560)
Preclinical (10995)
Press Release (72)
Prostate cancer (353)
Psychedelics (73)
Radiopharmaceuticals (375)
Rare diseases (1289)
Real estate (7462)
Recruiting (81)
Regulatory (30488)
Reports (77)
Research institute (2773)
Resumes & cover letters (654)
Rett syndrome (44)
RNA editing (30)
RSV (100)
Schizophrenia (197)
Series A (339)
Series B (244)
Service/supplier (28)
Sickle cell disease (128)
Special edition (32)
Spinal muscular atrophy (191)
Sponsored (55)
Startups (4373)
State (2)
Stomach cancer (21)
Supply chain (149)
Tariffs (104)
The Weekly (145)
Vaccines (1317)
Venture capital (139)
Weight loss (601)
Women's health (144)
Worklife (24)
Date
Today (116)
Last 7 days (461)
Last 30 days (2806)
Last 365 days (33191)
2026 (16973)
2025 (33218)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (102)
Alaska (7)
Arizona (407)
Arkansas (16)
Asia (52357)
Australia (9201)
California (14513)
Canada (4053)
China (1603)
Colorado (624)
Connecticut (645)
Delaware (450)
Europe (120733)
Florida (2166)
Georgia (471)
Hawaii (4)
Idaho (70)
Illinois (1267)
India (105)
Indiana (671)
Iowa (26)
Japan (610)
Kansas (144)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1754)
Massachusetts (10630)
Michigan (427)
Minnesota (807)
Mississippi (7)
Missouri (165)
Montana (37)
Nebraska (31)
Nevada (155)
New Hampshire (92)
New Jersey (3852)
New Mexico (35)
New York (3819)
North Carolina (1951)
North Dakota (11)
Northern California (7219)
Ohio (454)
Oklahoma (27)
Oregon (55)
Pennsylvania (2850)
Puerto Rico (33)
Rhode Island (55)
South America (1668)
South Carolina (89)
South Dakota (2)
Southern California (5702)
Tennessee (233)
Texas (2372)
United States (51946)
Utah (433)
Vermont (2)
Virginia (374)
Washington D.C. (89)
Washington State (1192)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 884,610 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Therma Bright Announces Expanded U.S. Orders for Venowave and Mobilizes Supply Chain for Upcoming Sales Volume
June 23, 2026
·
1 min read
Press Releases
Calico Life Sciences Announces Fosigotifator Granted Breakthrough Therapy Designation by the U.S. FDA for the Treatment of Vanishing White Matter Disease
June 23, 2026
·
5 min read
Press Releases
Allergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE) in Canada, the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients
June 23, 2026
·
15 min read
Press Releases
Rapalogix Health Raises $20 Million in Series A Financing to Redefine the Future of Longevity-Based Skin Health
June 23, 2026
·
5 min read
Press Releases
Takeda’s Zasocitinib Achieved Significantly Greater Complete Skin Clearance Than Deucravacitinib in Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations
June 23, 2026
·
14 min read
Press Releases
Quoin Pharmaceuticals Receives FDA Conditional Approval of QYLEKI™ as the Proposed Brand Name for QRX003 for Netherton Syndrome
June 23, 2026
·
6 min read
Press Releases
Silexion Therapeutics Receives Approval from Germany’s BfArM to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
June 23, 2026
·
7 min read
Press Releases
NCCN Recommends ctDNA-MRD Testing Using Signatera™ Technology in Landmark Bladder Cancer Guideline Update
June 23, 2026
·
4 min read
Press Releases
TRIMTECH Therapeutics Brings Total Seed Round to $47M with Additional Investment of $14M to Further Develop TRIMTAC and TRIMGLUE Targeted Protein Degradation Portfolio
June 23, 2026
·
1 min read
Press Releases
Phathom Pharmaceuticals Completes Patient Enrollment Ahead of Schedule in Phase 2 pHalcon-EoE-201 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE)
June 23, 2026
·
14 min read
1 of 88,461
Next
